DOV 21947 hydrochloride
CAS No. 410074-74-7
DOV 21947 hydrochloride ( Amitifadine hydrochloride )
Catalog No. M14409 CAS No. 410074-74-7
Amitifadine hydrochloride is a triple reuptake inhibitor (TRI) or serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI).
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 128 | In Stock |
|
5MG | 260 | In Stock |
|
10MG | 447 | In Stock |
|
25MG | 702 | In Stock |
|
50MG | 981 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDOV 21947 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionAmitifadine hydrochloride is a triple reuptake inhibitor (TRI) or serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI).
-
DescriptionAmitifadine hydrochloride is a triple reuptake inhibitor (TRI) or serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI). Ki values for SERT/NET/ DAT are 99/262/213 nM. The IC50 values for serotonin, norepinephrine and dopamine reuptake are 12/23/96 nM.
-
SynonymsAmitifadine hydrochloride
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor5-HT; Dopamine; Norepinephrine (NE)
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number410074-74-7
-
Formula Weight264.58
-
Molecular FormulaC11H12Cl3N
-
Purity>98%(HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESC1[C@H]2[C@@]1(CNC2)C3=CC(=C(C=C3)Cl)Cl.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Skolnick P, et al. Eur J Pharmacol. 2003 Feb 14;461(2-3):99-104.
molnova catalog
related products
-
F-11440
A potent, selective 5-HT1A receptor agonist with Ki of 4.8 nM, pKi of 8.33.
-
Ondansetron hydrochl...
Ondansetron is a serotonin 5-HT receptor antagonist used mainly as anantiemetic (to treat nausea and vomiting), often following chemotherapy.
-
RU-24969
A potent, selective agonist of 5-HT1A and 5-HT1B receptors, with preference for 5-HT1B.